HGP0816 clinical trials
Also written HGP0816.
How each study uses HGP0816 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- HGP0816
- 3
Studies by the year they started
4 studies that test it; most in 2014 (3)
| Year | Studies |
|---|---|
| 2014 | 3 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
HGP1404 (1) · HCP1306 (1) · Amlodipine (1) · HGP0918 (1)
Studies
Open first, then newest update. How each study uses HGP0816 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Evaluate the Pharmacokinetics and Safety of HCP1306 and Co-administration of HGP0816, HGP1404 in Healthy Male VolunteersCompletedPhase 1Hanmi Pharmaceutical Company LimitedNCT02941848Written as HGP0816
- Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and DyslipidemiaCompletedPhase 3Hanmi Pharmaceutical Company LimitedNCT02899455Written as HGP0816
- Efficacy/Safety of HCP1306 Tablet Versus HGP0816 Tablet in Patients With Primary HypercholesterolemiaCompletedPhase 3Hanmi Pharmaceutical Company LimitedNCT02205606Written as HGP0816 5mg
- Evaluating a Pharmacokinetic Drug Interaction Between HGP0918 and HGP0816CompletedPhase 1Hanmi Pharmaceutical Company LimitedNCT02554136Written as HGP0816